Sign inJoin waitlistJoin the waitlist

Michael Kappelman

Professor, Pediatric Gastroenterology · Duke University Hospital

Credentials: · · · · ·

History

Duke University Hospital
Present
Duke University Hospital
Present
University of North Carolina Hospitals
Present

Gastroenterology
Duke University Hospital
2007–2010
Harvard University
2006–2007
Pediatric Gastroenterology
Massachusetts General Hospital and Boston Children’s Hospital
2004–2007
Pediatric Health Services Research
Pediatrics
Massachusetts General Hospital
2001–2004
Harvard School of Public Health
Washington University School of Medicine
1997–2001
Washington University
1993–1997

Research

Burden of gastrointestinal disease in the United States: 2012 update
Gastroenterology · 2012 · 1,502 citations
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
Clinical Gastroenterology and Hepatology · 2007 · First of 7 authors · Corresponding · 735 citations
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Gastroenterology · 2020 · Last of 15 authors · 590 citations

Millie Long
96 papers
Robert Sandler
63 papers
Erica Brenner
32 papers · 32 as a resident
James Lewis
29 papers
Ryan Ungaro
29 papers
Edward Barnes
26 papers
Hans Herfarth
26 papers
AB
Athos Bousvaros
24 papers
Jean-Frederic Colombel
22 papers
JH
Jeffrey Hyams
22 papers
WC
Wallace Crandall
22 papers
Joel Rosh
19 papers

Grants

RFA-DP-23-002, Improving Outcomes and Reducing Disparities for Patients with Inflammatory Bowel Disease Through Epidemiology, Enhanced Disease Management, Dissemination, and Education
NCCDPHP · U01
Contact PI · $2.2M · Univ of North Carolina Chapel Hill
2023–2028
Diversity Within the Incidence, Prevalence, Treatment and Outcomes of Patients with IBD
NCCDPHP · U01
PI · $3.4M · Crohn's and Colitis Fdn of America, Inc.
2018–2023
The Child-Centered Outcomes in Practice and Research (COPR) Center of Excellence: Strengthening the Clinical Validity Evidence Base for PROMIS Measures in Chronically Ill Children
National Institute of Arthritis and Musculoskeletal and Skin Diseases · U19
Project lead · $753.1K · Children's Hosp of Philadelphia
2021
Enhancing Clinical Meaningfulness And Usefulness Of PROMIS Pediatric Measures Via Validation In Children And Adolescents With Rheumatic Disease, Cancer, Or Inflammatory Bowel Disease
National Institute of Arthritis and Musculoskeletal and Skin Diseases · U19
Project lead · $554K · Duke University
2017

Clinical trials

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management
Principal investigator · Enrolling by invitation
University of North Carolina, Chapel Hill
2024–2028
Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)
Principal investigator · Completed
University of North Carolina, Chapel Hill
2019–2022
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Study director · Completed · Phase 3
University of North Carolina, Chapel Hill
2016–2022